Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Journal of Science and Clinical Pharmacy Research
Devahimer Harsep Rosi
Universitas Mohammad Natsir Bukittinggi, Indonesia
Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
GAMBARAN TINGKAT PENGETAHUAN OBAT ORAL KORTIKOSTEROID DI APOTEK NEW BINTANG ILAHI BUKITTINGGI Eka Rahmadani; Devahimer Harsep Rosi; Miftahul Jannah
Journal of Science and Clinical Pharmacy Research Vol. 2 No. 1 (2026): February 2026
Publisher : LPPM Universitas Mohammad Natsir Bukittinggi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.1144/jscpr.v2i1.422

Abstract

The use of corticosteroids in the community is still quite high, even though these drugs are classified as strong medicines that should only be used with a doctor's prescription. Insufficient knowledge regarding indications, methods of use, and side effects can pose serious health risks. This study aims to determine the level of patient knowledge regarding the use of corticosteroid drugs and the types of corticosteroid drugs purchased at the New Bintang Ilahi Pharmacy in Bukittinggi. The research method used is descriptive prospective with data collection through questionnaires administered to 85 respondents during June 2025. The research results show that the respondents' level of knowledge regarding corticosteroid use is low, with an average correct score of 56.91%. The distribution of knowledge levels is: poor category 55.3%, sufficient 34.1%, and good 10.6%. The most frequently purchased type of corticosteroid was Dexamethasone 0.5 mg (57.64%), followed by Methylprednisone 4 mg and prednisolone 4 mg (35.29%). The conclusion of this study is that the majority of patients at the New Bintang Ilahi Pharmacy in Bukittinggi have a low level of knowledge regarding the use of corticosteroids, therefore more optimal education and counseling from pharmacy personnel is needed.
Evaluasi Penggunaan Antibiotik Pada Pasien Bronkopneumonia Anak Di Ruang Perawatan Melati Rsud Mukomuko Tahun 2024 Elsa Febria Mutiara; Ariesta Kirana Efmisa; Devahimer Harsep Rosi; Aivi Yola Dwiputri
Journal of Science and Clinical Pharmacy Research Vol. 2 No. 1 (2026): February 2026
Publisher : LPPM Universitas Mohammad Natsir Bukittinggi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.1144/jscpr.v2i1.433

Abstract

Bronchopneumonia is an inflammatory lung condition affecting one or more lobes, characterized by infiltrative patches caused by bacteria, viruses, fungi, and foreign substances. The purpose of this study was to obtain an overview and analysis of the appropriateness of antibiotic use. This was a descriptive observational study with a retrospective approach using secondary medical record data. The results for the description of antibiotic use were Seftriakson (53.4%), Sefotaksim (27.6%), and meropenem (19.0%). The results of the quality assessment using the Gyssens Method revealed that 1.7% of antibiotic prescriptions were in category III B, 19% in category IV A, and 79.3% in category 0. These data indicate that there is still irrational use of antibiotics. Assessed using the ATC/DDD methodology, resulting in a total of 25.57 DDD per 100 days. The calculation findings show the highest Defined Daily Dose (DDD) value for the antibiotic Seftriakson at 18.06 DDD per 100 days of hospitalization, while the lowest value was seen for Meropenem at 2.09 DDD per 100 days and Sefotaksim at 5.42 DDD per 100 days of hospitalization. Clinical parameters showed a P value > 0.05, with p = 0.88, indicating no statistically significant difference between antibiotic administration and leukocyte levels in pediatric bronchopneumonia patients in the Melati ward at Mukomuko Hospital in 2024.
Co-Authors Aivi Yola Dwiputri Ariesta Kirana Efmisa Eka Rahmadani Elsa Febria Mutiara Miftahul Jannah